Building a Leading Pharma Company for Canada and Latin America
Knight Therapeutics Reports Second Quarter 2023 Results
MONTREAL, Aug. 10, 2023 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2023. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.
Notice of Knight Therapeutics’ Second Quarter 2023 Results Conference Call
MONTREAL, Aug. 03, 2023 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2023 financial results on Thursday, August 10, 2023 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
You are now leaving the Knight Canada website and entering other country website where the information presented may have different labeling than in Canada, and the Canadian Privacy Policy does not apply. You are solely responsible for your interactions with that website.
Click here to continue
You are now leaving the Knight Canada website and entering other country website where the information presented may have different labeling than in Canada, and the Canadian Privacy Policy does not apply. You are solely responsible for your interactions with that website.
Click here to continue
You are now leaving the Knight Canada website and entering other country website where the information presented may have different labeling than in Canada, and the Canadian Privacy Policy does not apply. You are solely responsible for your interactions with that website.
Click here to continue